Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

[Plasma levels of alpha-fetoprotein and carcinoembryonic antigen in patients with malignant gastrointestinal tumors].

Monteiro JC, Moreira MM, Pereira FE, de Oliveira LR, da Cunha EA, Leite JF, Castro e Sousa F.

Acta Med Port. 1989 Nov-Dec;2(6):245-52. Review. Portuguese.

2.

Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.

Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R.

Anticancer Res. 2000 Nov-Dec;20(6D):5195-8.

PMID:
11326694
3.

Preoperative serum levels of CA 72-4, CEA, CA 19-9, and alpha-fetoprotein in patients with gastric cancer.

Mattar R, Alves de Andrade CR, DiFavero GM, Gama-Rodrigues JJ, Laudanna AA.

Rev Hosp Clin Fac Med Sao Paulo. 2002 May-Jun;57(3):89-92.

6.

The incidence and significance of serum hCG and CEA in patients with gastrointestinal malignant tumors.

Birkenfeld S, Noiman G, Krispin M, Schwartz S, Zakut H.

Eur J Surg Oncol. 1989 Apr;15(2):103-8.

PMID:
2703054
7.

Plasma carcinoembryonic antigen in the diagnosis and management of patients with hepatocellular carcinoma.

Melia WM, Johnson PJ, Carter S, Munro-Neville A, Williams R.

Cancer. 1981 Aug 15;48(4):1004-8.

8.

Diagnostic value of serum tumor markers in asymptomatic individuals.

Eleftheriadis N, Papaloukas C, Pistevou-Gompaki K.

J BUON. 2009 Oct-Dec;14(4):707-10.

PMID:
20148467
10.

Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.

Ando S, Kimura H, Iwai N, Shima M, Ando M, Kuriyama T.

Anticancer Res. 2001 Jul-Aug;21(4B):3085-92.

PMID:
11712815
11.

Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer.

Carpelan-Holmström M, Haglund C, Lundin J, Järvinen H, Roberts P.

Eur J Cancer. 1996 Jun;32A(7):1156-61.

PMID:
8758246
12.

Cell-surface levels of human carcinoembryonic antigen are inversely correlated with colonocyte differentiation in colon carcinogenesis.

Ilantzis C, Jothy S, Alpert LC, Draber P, Stanners CP.

Lab Invest. 1997 May;76(5):703-16.

PMID:
9166289
13.

Clinical applications of serum carcinoembryonic antigen and alpha-fetoprotein levels in children with solid tumours.

Mann JR, Lakin GE, Leonard JC, Rawlinson HA, Richardson SG, Corkery JJ, Cameron AH, Shah KJ.

Arch Dis Child. 1978 May;53(5):366-74.

14.

The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer.

Moertel CG, O'Fallon JR, Go VL, O'Connell MJ, Thynne GS.

Cancer. 1986 Aug 1;58(3):603-10.

15.

Carbohydrate 19-9 antigen as a marker of non-malignant hepatocytic ductular transformation in patients with acute liver failure. A comparison with alpha-fetoprotein and carcinoembryonic antigen.

Halme L, Kärkkäinen P, Isoniemi H, Mäkisalo H, von Bogulawski K, Höckerstedt K.

Scand J Gastroenterol. 1999 Apr;34(4):426-31.

PMID:
10365905
16.

Prognostic significance of CEA and CA 19-9 in colorectal cancer in Kuwait.

Behbehani AI, Al-Sayer H, Farghaly M, Kanawati N, Mathew A, al-Bader A, Van Dalen A.

Int J Biol Markers. 2000 Jan-Mar;15(1):51-5.

PMID:
10763141
17.

A new radioimmunoassay detecting early stages of colon cancer: a comparison with CEA, AFP, and Ca 19-9.

Chester SJ, Maimonis P, Vanzuiden P, Finklestein M, Bookout J, Vezeridis MP.

Dis Markers. 1991 Sep-Oct;9(5):265-71.

PMID:
1724634
18.
19.

Determination of carcinoembryonic antigen levels in peripheral and draining venous blood in patients with colorectal carcinoma.

Waisberg J, Contim-Neto L, Oliveira Mda S, Matheus Cde O, Nagashima CA, Goffi FS.

Arq Gastroenterol. 2004 Apr-Jun;41(2):88-92. Epub 2004 Oct 27.

20.

Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer.

Ucar E, Semerci E, Ustun H, Yetim T, Huzmeli C, Gullu M.

Adv Ther. 2008 Oct;25(10):1075-84. doi: 10.1007/s12325-008-0100-4.

PMID:
18821070

Supplemental Content

Support Center